Relapsed and refractory classical Hodgkin lymphoma: could virotherapy help solve the equation?

• मुख्य लेखकों: Selma Addou (लेखक), Clémentine Sarkozy (लेखक), Julien Lazarovici (लेखक), Stéphane Champiat (लेखक), Aspasia Stamatoullas (लेखक), Fabrice Jardin (लेखक), Vincent Ribrag (लेखक), Aurélien Marabelle (लेखक), Jean-Marie Michot (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Taylor & Francis Group, 2021-10-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Classical Hodgkin lymphoma is a neoplastic hematological disease. Standard first-line therapy, including chemotherapy and radiotherapy, is curative in >85% of early-stage patients, with a 5-year survival rate of >95%. However, approximately 15% of patients have hard-to-treat lymphoma with poor...